Statistics
Publications
156
Citations
25.9K
H-Index
67
Active since
2002
Jun Qi is an author at Dana-Farber Cancer Institute specializing in molecular oncology, medicine, and oncology.
Publications per year
2002–2025
156
156
Selective inhibition of BET bromodomains
P. Filippakopoulos, Jun Qi, S. Picaud et al. · Nature · 2010 · 4.3K citations · Full text
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake Delmore, Ghayas C. Issa, Madeleine E. Lemieux et al. · Cell · 2011 · 2.8K citations · Full text
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber, Junwei Shi, Eric Wang et al. · Nature · 2011 · 1.9K citations
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su, Lei Dong, Chenying Li et al. · Cell · 2017 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +10
The dTAG system for immediate and target-specific protein degradation
Behnam Nabet, Justin M. Roberts, Dennis L. Buckley et al. · Nature Chemical Biology · 2018 · 1.2K citations · Full text
1–5 of 156